The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson Disease

The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine60 enrolled

Overview

In order to expand the treatment of Wilson disease and improve the quality of life of patients with Wilson's disease, the clinical effect of botulinum toxin type A injection on Wilson's disease was discussed.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Wilson Disease

Interventions

Botulinum toxin type ADRUG

Local injection of botulinum toxin type A was given at the time of enrollment

Eligibility

Sex: ALLMin age: 15 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria：1.Conform to the diagnosis of "2012 European Liver Study Guidelines for Diagnosis and Treatment of hepatolenticular degeneration". 2. Aged from 15 to 65 years. Exclusion Criteria:Non-Wilson's disease

Locations (1)

the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, #117 Meishan Street, Shushan District Hefei 230037, China

Hefei, China

Outcomes

Primary Outcomes

Unified Dystonia Rating Scale(UDRS)

Unified Dystonia Rating Scale(UDRS),Higher scores mean a worse outcome.

Time frame: 4 weeks

Unified Wilson's Disease Rating Scale(UWDRS)

Unified Wilson's Disease Rating Scale(UWDRS).Higher scores mean a worse outcome

Time frame: 4 weeks

Numeric Rating Scales(NRS)

Numeric Rating Scales(NRS),Higher scores mean a worse outcome

Time frame: 4 weeks

Activity of Daily Living Scale(ADL)

Activity of Daily Living Scale,Higher scores mean a better outcome.

Time frame: 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.